Arizona 2023 2023 Regular Session

Arizona Senate Bill SB1052 Comm Sub / Analysis

Filed 02/21/2023

                    Assigned to COM 	AS PASSED BY COW 
 
 
 
 
ARIZONA STATE SENATE 
Fifty-Sixth Legislature, First Regular Session 
 
AMENDED 
FACT SHEET FOR S.B. 1052 
 
biomarker testing; insurance coverage; definitions 
(NOW: insurance coverage; biomarker testing) 
Purpose 
Excludes limited benefit coverage from a policy issued or renewed by a disability insurer 
or group or blanket disability insurer for the purpose of providing coverage of biomarker testing. 
Background 
The Department of Insurance and Financial Institutions regulates policies, certificates, 
evidences of coverage and contracts of insurance that are issued or delivered by health care 
insurers. Health care insurers include disability insurers, group disability insurers, blanket 
disability insurers, health care services organizations, hospital service corporations and medical 
service corporations (A.R.S. § 20-1379). 
 In 2022, the Legislature enacted legislation to require, for contracts, evidences of coverage 
and policies issued, a hospital or medical service corporation, health care service organization, 
disability insurer and group or blanket disability insurer to provide biomarker testing (Laws 2022, 
Ch. 219). Biomarker testing aids in the diagnosing and monitoring of cancer during and after 
treatment. Each person's cancer presents a unique pattern of biomarkers and some cancer 
treatments may only work for individuals whose cancers have certain biomarkers (NCI).  
Statute defines limited benefit coverage as an insurance policy that is designed, advertised 
and marketed to supplement major medical insurance and that includes accident only, dental only, 
vision only, disability income only, fixed or hospital indemnity, specified disease insurance, credit 
insurance or Taft-Hartley trusts (A.R.S. § 20-1137). 
There is no anticipated fiscal impact to the state General Fund associated with this 
legislation. 
Provisions 
1. Excludes limited benefit coverage from a policy issued or renewed by a disability insurer or 
group or blanket disability insurer for the purpose of providing coverage of biomarker testing.  
2. Makes technical and conforming changes. 
3. Becomes effective on the general effective date. 
Amendments Adopted by Committee 
• Adopted the strike-everything amendment.   FACT SHEET – Amended  
S.B. 1052 
Page 2 
 
 
Senate Action  
COM 2/8/23 DPA/SE 6-0-1 
Prepared by Senate Research 
February 20, 2023 
JT/sr